• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

MRI Detects Additional Breast Cancers After Conservation Therapy

Article

Magnetic resonance imaging detected additional cancers among women who underwent breast conservation therapy following early diagnosis of breast cancer.

Single-screening MRI found additional cancers among women with a history of breast conservation therapy (BCT), according to a study published in the journal Radiology.

Korean researchers undertook a retrospective study to determine the outcomes of single-screening breast MRI in women who had a history of BCT for breast cancers.

The study group comprised 607 women (median age 48 years) who underwent BCT for breast cancer, had negative mammography and US findings, and underwent subsequent screening breast MR imaging. A total of 557 women (91.8 percent) underwent preoperative MR examinations. The researchers assessed cancer detection rate, characteristics of detected cancers, positive predictive value (PPV), sensitivity, and specificity.

Results showed additional findings by MRI of 11 cancers (eight invasive, three ductal carcinoma in situ) for 18.1 cancers per 1,000 women. The median invasive size was 0.8 cm (range, 0.4–1.4 cm). All were node negative. PPV for recall was 9.4 percent (11 of 117 examinations; PPV for biopsy: 43.5 percent (10 of 23 examinations); sensitivity: 91.7 percent (11 of 12 examinations); and specificity: 82.2 percent (489 of 595 examinations).

“At multivariate analysis, the independent factors associated with women with MR-detected cancers were age younger than 50 years at initial diagnosis and more than a 24-month interval between initial surgery and screening MR imaging,” the authors wrote.

 

Recent Videos
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
Teleradiology and Breast Imaging: Keys to Facilitating Personalized Service, Efficiency and Equity
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
Can Mammography-Based AI Enhance Breast MRI Use in Patients with Intermediate Risk for Breast Cancer?

Can Mammography-Based AI Enhance Breast MRI Use in Patients with Intermediate Risk for Breast Cancer?

Jeff Hall
February 4th 2025
Article

For women with intermediate risk and a personal history of breast cancer, an emerging AI system offered an 81 percent AUC for breast cancer detection, according to new research.

The Reading Room Podcast: Emerging Concepts in Breast Cancer Screening and Health Equity Implications, Part 3

The Reading Room Podcast: Emerging Concepts in Breast Cancer Screening and Health Equity Implications, Part 3

Jeff Hall
September 1st 2023
Podcast

In the third episode of a three-part podcast, Anand Narayan, M.D., Ph.D., and Amy Patel, M.D., discuss the challenges of expanded breast cancer screening amid a backdrop of radiologist shortages and ever-increasing volume on radiology worklists.

Multimodal AI with CCTA and MRI Data Shows Promise in Predicting MACE in Patients with Obstructive CAD

Multimodal AI with CCTA and MRI Data Shows Promise in Predicting MACE in Patients with Obstructive CAD

Jeff Hall
January 29th 2025
Article

For patients with newly diagnosed obstructive coronary artery disease (CAD), a multimodal machine learning model offered an 86 percent AUC for predicting MACE, which was 10 percent higher than CCTA alone and over 35 percent higher than the Framingham Risk Score.

The Reading Room Podcast: Emerging Concepts in Breast Cancer Screening and Health Equity Implications, Part 2

The Reading Room Podcast: Emerging Concepts in Breast Cancer Screening and Health Equity Implications, Part 2

Jeff Hall
August 23rd 2023
Podcast

In the second episode of a three-part podcast, Anand Narayan, M.D., Ph.D., and Amy Patel, M.D., discuss recent studies published by the Journal of the American Medical Association (JAMA) that suggested moving to more of a risk-adapted model for mammography screening.

MRI Study Reveals Early Differences in Mild Cognitive Impairment Preceding Alzheimer’s Disease and Parkinson’s Disease

MRI Study Reveals Early Differences in Mild Cognitive Impairment Preceding Alzheimer’s Disease and Parkinson’s Disease

Jeff Hall
January 21st 2025
Article

For patients with mild cognitive impairment (MCI), early changes with respect to decreased intra-network connectivity involving the default mode network or salience network may aid in differentiating between the development of Alzheimer’s disease and Parkinson’s disease, according to new MRI research.

Seven Takeaways from New CT and MRI Guidelines for Ovarian Cancer Staging

Seven Takeaways from New CT and MRI Guidelines for Ovarian Cancer Staging

Jeff Hall
January 20th 2025
Article

In an update of previous guidelines from the European Society of Urogenital Radiology published in 2010, a 21-expert panel offered consensus recommendations on the utility of CT, MRI and PET-CT in the staging and follow-up imaging for patients with ovarian cancer.

© 2025 MJH Life Sciences

All rights reserved.